Teclistamab in Previously Treated AL Amyloidosis
Clinical trial NCT06935162 · RECRUITING
Trial details
- NCT number
- NCT06935162
- Sponsor
- Peking Union Medical College Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-21
- Primary completion
- 2026-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.